To manufacture and supply Opium derived Alkaloids & APIs to the Govt. of India
Bajaj Healthcare announced that it has received two letters of Award on 12 July, 2022, for the manufacture of Alkaloids/APIs from Government of India, Department of Revenue, Office of Chief Controller, Govt. Opium & Alkaloid Factories as follows:1. Letter of Award, to manufacture Alkaloids & APIs from processing of 500 MT of unlanced poppy capsule along with Straw on an annual basis.
2. Letter of Award, to manufacture Alkaloids & APIs from processing of 100 MT of Opium Gum on an annual basis.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app